Mirae Asset Global Etfs Holdings Ltd. Astrazeneca PLC Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 472,062 shares of AZN stock, worth $40.3 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
472,062
Previous 489,083
3.48%
Holding current value
$40.3 Million
Previous $35.9 Million
8.23%
% of portfolio
0.07%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,412Shares Held
496MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.43 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.52 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.93 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.68 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.66 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $265B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...